Biotech IPOs, Cuts, and Leadership Change
Kilder
- BioPharma Dive: Parkinson’s cell therapy developer files to go public
- GEN: StockWatch: Caribou Plunges as It Pursues Strategic Alternatives
- Endpoints: Brent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year run
- Reuters: Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief - Reuters
- Wncy: Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief - Y100 WNCY
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.